Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1235514-15-4
1807503-86-1
1951439-46-5
252378-66-8
252378-68-0
1895922-74-3
2028288-77-7 | Tco-peg3-amine | AA019E5O | MFCD30458038
2100306-73-6 | Benzyloxy carbonyl-peg3-acid | AA019EAC | MFCD30723204
1844894-82-1 | t-Boc-aminooxy-PEG1-amine | AA019EEE | MFCD31561111
346577-65-9 | 1-Benzyl-5-ethoxy-1,3-dihydro-indol-2-one | AA019EI0 | MFCD09833651
312507-33-8 | N-(4-Methoxyphenyl)-6-methylpyrimidin-4-amine | AA019EKS | MFCD01461307
349404-77-9 | 4-bromo-N-(4-iodophenyl)benzenesulfonamide | AA019EO9 | MFCD00595028
139524-56-4 | 6,6-Dimethylpiperidin-2-one | AA019ERH | MFCD03085968
1823258-71-4 | tert-Butyl 7-(4-bromophenyl)-5-oxo-2,6-diazaspiro[3.4]octane-2-carboxylate | AA019EUH | MFCD27997382
37673-08-8 | 2-(2-Methoxyphenyl)-2-morpholinoacetonitrile | AA019EXJ | MFCD10005143
242478-37-1 | Solifenacin | AA019FPZ | MFCD18910847